Company Analysis
Sign in

Abeona Therapeutics Inc. (ABEO)

Nasdaq: ABEO · Pharmaceutical Preparations · Cleveland, OH · filing with the SEC since 1995
Full chart Alerts Compare
Grade5.5
◀ Past 4.3● Present 5.5▶ Future 6.3
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue$5.8M+66.3%
Net income$71.2M+211.7%
Earnings per share$1.34+186.5%
Operating cash flow-$76.3M-36.3%
Cash$78.4M+235.8%
Debt$20.0M+5.7%
Shareholders’ equity$159M+261.6%
Shares, diluted53.0M+29.0%
Return on equity44.7%
The recordfrom its filings
Filings in 2026111
Newest filingNov 12 · SCHEDULE 13G/A
Annual reportMar 17, 2026
Quarterly reportNov 9, 2026
Next report due10-K by Mar 31
Insider sales, 12 months$3.6M
Insider buys, 12 months$0.00
Patents granted43
Filer categoryNon-accelerated filer<br>Smaller reporting company
Trailing twelve months to Sep 2026Revenue $39.0MNet income -$62.5MCash from operations -$63.6Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
16171819202122232425
As filed, in USD. Nothing here is a forecast.

News

Nov 9, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Nov 9, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Nov 9, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Oct 23, 2026 · SEC EDGAR · Form SCHEDULE 13D
Activist holder notice
Open the filing on sec.gov
Sep 29, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton ABEO · research, not advice